IPVS 2000

Efficacy of a modified live porcine reproductive and respiratory sydrome virus vaccine against heterologous virulent Lelystad challenge

10 minutes
Expertise article | IPVS 2000
M. B. Roof, D. Gorcyca, D. Wensvoort. IPVS. 2000

In conclusion, this summary confirms the ability of a modified live PRRS vaccine (Ingelvac® PRRS MLV) to provide heterologous protection following virulent challenge with the European LV strain of PRRS.

The use of Ingelvac PRRS - MLV for herd specific elimination of PRRSV from piglets born to a PRRSV-positive sow population

10 minutes
Expertise article | IPVS 2000
S. Pesch, V. F. Ohlinger. IPVS. 2000

Ingelvac PRRS MLV was shown to reduce European PRRSV field strains from infected populations significantly. In distinct herds with well control health management and production systems, PRRSV could be eliminated from piglets produced from sows vaccinated